Actively Recruiting
Clinicopathological Analysis of Endometrial Carcinoma in the View of Old and New International Federation of Gynecology and Obestetrics (FIGO)
Led by Assiut University · Updated on 2024-10-15
110
Participants Needed
1
Research Sites
50 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Assess the percentage change in stage and risk stratification for patients with endometrial cancer when transitioning from the FIGO 2009 endometrial staging system to the updated FIGO 2023 endometrial staging system. Investigate the prognostic impact of the FIGO 2023 endometrial staging system on patient survival. Evaluate how the shift in stage classification between the FIGO 2009 and FIGO 2023 systems influences adjuvant management decisions for endometrial cancer.
CONDITIONS
Official Title
Clinicopathological Analysis of Endometrial Carcinoma in the View of Old and New International Federation of Gynecology and Obestetrics (FIGO)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients diagnosed with endometrial cancer who underwent surgical staging (total hysterectomy and bilateral salpingo-oophorectomy) between January 1, 2018, and December 31, 2022
- Available medical records since diagnosis with at least 2 years follow-up
- Received adjuvant treatment
- Available histopathological slides and blocks
You will not qualify if you...
- Patients who received neoadjuvant chemotherapy
- Patients with recurrent endometrial cancer
- Patients with multiple cancers
- Lack of histopathological slides and formalin-fixed paraffin-embedded blocks
- Lack of medical records
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Assiut university
Asyut, Egypt, 71515
Actively Recruiting
Research Team
Y
Yousra H Abdelghafour, MBBCH
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here